title: Targeted therapy for colorectal cancer resistance to EGF receptor antibodies and new trends.
authors.forename: Christos
authors.initials: C
authors.lastname: Katsios
authors.forename: Denosthenes E
authors.initials: DE
authors.lastname: Ziogas
authors.forename: Dimitrios H
authors.initials: DH
authors.lastname: Roukos
authors.forename: George
authors.initials: G
authors.lastname: Baltogiannis
mesh_terms: D000906:Antibodies / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000276:immunology; D019008:Drug Resistance, Neoplasm; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000276:immunology; D006801:Humans; D058990:Molecular Targeted Therapy; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D047428:Protein Kinase Inhibitors; C512478:EGFR protein, human; D066246:ErbB Receptors